Cafepharma Today

June 9 2025 - Merck claims study success with PCSK9 cholesterol pill
Merck claims study success with PCSK9 cholesterol pill
FDA limits Merck's Keytruda, Bristol Myers' Opdivo in stomach cancer
Drug imports plummeted in April despite tariff threat
Sanofi starts shipping RSV drug early as rival nears market
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Analysis: For Merck, bringing cattle feed Zilmax back won't be easy
Yahoo/Reuters
Friday, November 1, 2013 - 8:34am
tags:
Merck, Zilmax, animal health
The Wisdom -- And Risk -- Of Pfizer's New Cholesterol Drug Development Plan
Forbes
Friday, November 1, 2013 - 8:28am
tags:
Pfizer, PCSK9 inhibitors, RN-316, Sanofi, Regeneron, REGN727, AMG145, Amgen
2 Drug Promotions Going in Opposite Directions
Motley Fool
Friday, November 1, 2013 - 8:26am
tags:
Amarin, Vascepa, Arena Pharmaceuticals, Eisai
Judge Invalidates Patent for a Down Syndrome Test
NY Times, NY
Friday, November 1, 2013 - 8:23am
tags:
Downs Syndrome, patents, Sequenom
Clovis Oncology's CEO Discusses Q3 2013 Results - Earnings Call Transcript
Seeking Alpha
Friday, November 1, 2013 - 8:22am
tags:
earnings, Clovis Oncology
Uh Oh Arena Pharma! Q3 Belviq Sales Just $4.8M
TheStreet.com
Friday, November 1, 2013 - 8:20am
tags:
Arena Pharmaceuticals, Belviq, Eisai, obesity
Novo Nordisk recruiting 400 U.S. sales reps as growth decelerates
Fierce Pharma
Thursday, October 31, 2013 - 11:36am
tags:
hirings, Novo Nordisk
Bayer Third-Quarter Earnings Rise on New Medicines
Bloomberg
Thursday, October 31, 2013 - 11:33am
tags:
earnings, Bayer
Mazor Robotics prices $41M offering
Mass Device
Thursday, October 31, 2013 - 11:32am
tags:
Mazor Robotics, stock offering, devices
Smith & Nephew names new chairman, posts Q3 profit slip
Mass Device
Thursday, October 31, 2013 - 11:31am
tags:
Smith & Nephew, earnings, devices
Reckitt Heroin-Abuse Drug Seen Luring Shire: Real M&A
Bloomberg
Thursday, October 31, 2013 - 11:30am
tags:
Reckitt Benckiser, heroin abuse, Shire, M&A, Suboxone, Actavis
New two-hormone Roche drug shows promise in diabetes, obesity
Reuters
Thursday, October 31, 2013 - 11:29am
tags:
Roche, obesity, diabetes, GLP-1 agonist
Drug-maker Valeant eyes small and large M&A deals
Reuters
Thursday, October 31, 2013 - 11:23am
tags:
M&A, Valeant Pharmaceuticals
CytRx's aldoxorubicin shows further positive interim data in Phase 2b trial
The Fly on the Wall
Thursday, October 31, 2013 - 11:21am
tags:
CytRx, aldoxorubicin, soft tissue sarcomas
EntreMed commences ENMD-2076 Phase 2 trial
The Fly on the Wall
Thursday, October 31, 2013 - 11:16am
tags:
ENMD-2076, EntreMed, ovarian cancer
DOJ wants info from AstraZeneca about heart drug study
Bizjournals.com
Thursday, October 31, 2013 - 10:15am
tags:
DOJ, AstraZeneca, Brilinta
Pfizer Vs. Novartis: A New Era In Breast Cancer Treatment
Seeking Alpha
Thursday, October 31, 2013 - 9:38am
tags:
Pfizer, Novartis, breast cancer, palbociclib, LEE011
Dr. Reddy’s Q2 & H1 FY14 Financial Results
Yahoo
Thursday, October 31, 2013 - 9:33am
tags:
Dr Reddy's, earnings
Teva Pharm Q3 profit, revenue top estimates
Yahoo/Reuters
Thursday, October 31, 2013 - 8:58am
tags:
Teva Pharmaceuticals, earnings
Teva gets approval from FDA for phase 3 heart failure trial
The Fly on the Wall
Thursday, October 31, 2013 - 8:58am
tags:
Teva, Mesoblast, FDA, congestive heart failure, Mesenchymal Precursor Cells

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Taurine and Aging: Is There Anything to It?
In the Pipeline
Cleaning Up the Medical Literature
In the Pipeline
Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.